knowledge -WSS

knowledge

author：knowledge 2025-09-06 02:03:46 - browse：286

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

The new medicine, called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics. Its authorization is a scientific triumph for the technology that can efficiently and precisely repair DNA mutations — ushering in a new era of genetic medicines for inherited diseases.

In a clinical trial, Casgevy was shown to eliminate recurrent episodes of debilitating pain caused by sickle cell, which afflicts approximately 100,000 people in the U.S., a vast majority of whom are Black. The therapy, whose scientific name is exa-cel, is described as a potential cure because the genetic fix enabled by CRISPR is designed to last a lifetime, although confirmation will require years of follow-up.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Eye stem cell transplant could help restore vision in injured people

hotspot

knowledge

WSS

As H5N1 spreads in cows, experts warn against drinking raw milk

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Oak Street deal isn't the answer to health care's woes

Lung cancer is America's deadliest cancer. Yet so few get screened

Listen: Racing for gene therapy & a pioneering approval

Listen: Racing for gene therapy & a pioneering approval

leisure time

knowledge

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Free medical tuition alone isn't enough to close gaps in primary care

Bright Health sells Medicare Advantage business to Molina

Patient advocates sound warning on FDA proposal on salt intake

Affirmative action in medical school literally saved lives

Cherokee Nation medical school graduates its first class

Hepatitis C has a cure — but many Americans still lack access to it

Lung cancer is America's deadliest cancer. Yet so few get screened

The high cost of giving birth even with insurance

ProMED sees offers of support, but its future remains unclear

leisure time

Abbott's new stent may help patients with peripheral artery disease

New details revealed about Purdue's marketing of OxyContin

STAT series 'Denied by AI' wins major journalism prizes

New details revealed about Purdue's marketing of OxyContin

Patient advocates sound warning on FDA proposal on salt intake

WuXi Biologics execs register to lobby as Congress comes for the company

Wikipedia

hotspot

knowledge

Wikipedia